Skip to Content
AP National Business

Japan approves Novavax COVID-19 vaccine

By
Published 12:02 AM

By MARI YAMAGUCHI
Associated Press

TOKYO (AP) — Japan’s health ministry formally approved Novavax’s COVID-19 vaccine, a fourth foreign-developed tool to combat the infections. The approval Tuesday comes just as the country sees signs of resurgence led by a subvariant of fast-spreading omicron. It is also the day after the ministry’s panel of experts endorsed use of the vaccine. Novavax’s protein vaccine is designed with similar technology used to fight diseases such as the flu and hepatitis B. Health Minister Shigeyuki Goto told reporters the Novavax product adds variety to the choices available and could appeal to those hesitant to use earlier COVID-19 vaccines designed with newer technologies. 

Article Topic Follows: AP National Business

Jump to comments ↓

Associated Press

BE PART OF THE CONVERSATION

ABC 17 News is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content